Annals of Oncology

in this issue:

in this issue
Ann Oncol 18: 967; doi:10.1093/annonc/mdm286
[Extract] [Full Text] [PDF] [Request Permissions]

editorial:

E Bajetta, A Gevorgyan, and H Mellstedt

National integration of European standards
Ann Oncol 18: 969-970; doi:10.1093/annonc/mdm122
[Extract] [Full Text] [PDF] [Request Permissions]

reviews:

PC Stone and S Lund

Predicting prognosis in patients with advanced cancer
Annals of Oncology Advance Access published on October 16, 2006
Ann Oncol 18: 971-976; doi:10.1093/annonc/mdl343
[Abstract] [Full Text] [PDF] [Request Permissions]

G Valabrega, F Montemurro, and M Aglietta

Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer
Annals of Oncology Advance Access published on January 17, 2007
Ann Oncol 18: 977-984; doi:10.1093/annonc/mdl475
[Abstract] [Full Text] [PDF] [Request Permissions]

P Boffetta

Epidemiology of peritoneal mesothelioma: a review
Annals of Oncology Advance Access published on October 9, 2006
Ann Oncol 18: 985-990; doi:10.1093/annonc/mdl345
[Abstract] [Full Text] [PDF] [Request Permissions]

original articles:

breast cancer:

G Mustacchi, ME Cazzaniga, P Pronzato, A De Matteis, F Di Costanzo, and I Floriani On behalf of the NORA Study Group

Breast cancer in elderly women: a different reality? Results from the NORA study
Annals of Oncology Advance Access published on March 9, 2007
Ann Oncol 18: 991-996; doi:10.1093/annonc/mdm063
[Abstract] [Full Text] [PDF] [Request Permissions]

A Di Leo, M Tanner, C Desmedt, M Paesmans, F Cardoso, V Durbecq, S Chan, T Perren, M Aapro, C Sotiriou, MJ Piccart, D Larsimont, and J Isola On behalf of the TAX 303 translational study team

p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial
Annals of Oncology Advance Access published on March 17, 2007
Ann Oncol 18: 997-1003; doi:10.1093/annonc/mdm075
[Abstract] [Full Text] [PDF] [Request Permissions]

D Treré, L Montanaro, C Ceccarelli, S Barbieri, G Cavrini, D Santini, M Taffurelli, and M Derenzini

Prognostic relevance of a novel semiquantitative classification of Bcl2 immunohistochemical expression in human infiltrating ductal carcinomas of the breast
Annals of Oncology Advance Access published on March 19, 2007
Ann Oncol 18: 1004-1014; doi:10.1093/annonc/mdm074
[Abstract] [Full Text] [PDF] [Request Permissions]

C Natoli, E Cianchetti, N Tinari, D Angelucci, A Grassadonia, M Zilli, C Ficorella, E Ricevuto, S Grossi, M De Tursi, C Carella, AI Rispoli, and S Iacobelli

A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer
Annals of Oncology Advance Access published on March 17, 2007
Ann Oncol 18: 1015-1020; doi:10.1093/annonc/mdm076
[Abstract] [Full Text] [PDF] [Request Permissions]

N Cabioglu, Y Gong, R Islam, KR Broglio, N Sneige, A Sahin, AM Gonzalez-Angulo, P Morandi, C Bucana, GN Hortobagyi, and M Cristofanilli

Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer
Annals of Oncology Advance Access published on March 9, 2007
Ann Oncol 18: 1021-1029; doi:10.1093/annonc/mdm060
[Abstract] [Full Text] [PDF] [Request Permissions]

gastrointestinal tumors:

JG Kim, SK Sohn, YS Chae, YY Cho, H-I Bae, G Yan, JY Park, M-H Lee, HY Chung, and W Yu

Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer
Annals of Oncology Advance Access published on April 10, 2007
Ann Oncol 18: 1030-1036; doi:10.1093/annonc/mdm085
[Abstract] [Full Text] [PDF] [Request Permissions]

lung cancer:

JP Sculier, JJ Lafitte, J Lecomte, CG Alexopoulos, O Van Cutsem, V Giner, A Efremidis, MC Berchier, T Collon, AP Meert, A Scherpereel, V Ninane, M Paesmans, and T Berghmans On behalf of European Lung Cancer Working Party

A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer
Annals of Oncology Advance Access published on April 2, 2007
Ann Oncol 18: 1037-1042; doi:10.1093/annonc/mdm084
[Abstract] [Full Text] [PDF] [Request Permissions]

L Taillade, F Penault-Llorca, T Boulet, P Fouret, S Michiels, E Taranchon, G Mountzios, P Validire, J Domont, P Girard, D Grunenwald, T Le Chevalier, and J-C Soria

Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer
Annals of Oncology Advance Access published on March 12, 2007
Ann Oncol 18: 1043-1050; doi:10.1093/annonc/mdm072
[Abstract] [Full Text] [PDF] [Request Permissions]

SA Laurie, K Ding, M Whitehead, R Feld, N Murray, FA Shepherd, and L Seymour

The impact of anemia on outcome of chemoradiation for limited small-cell lung cancer: a combined analysis of studies of the National Cancer Institute of Canada Clinical Trials Group
Ann Oncol 18: 1051-1055; doi:10.1093/annonc/mdm077
[Abstract] [Full Text] [PDF] [Request Permissions]

ITS Yu, LA Tse, CC Leung, TW Wong, CM Tam, and ACK Chan

Lung cancer mortality among silicotic workers in Hong Kong—no evidence for a link
Ann Oncol 18: 1056-1063; doi:10.1093/annonc/mdm089
[Abstract] [Full Text] [PDF] [Request Permissions]

urogenital tumors:

J-C Eymard, F Priou, A Zannetti, A Ravaud, D Lepillé, P Kerbrat, P Gomez, B Paule, D Genet, P Hérait, E Ecstein-Fraïssé, and F Joly

Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer
Annals of Oncology Advance Access published on April 13, 2007
Ann Oncol 18: 1064-1070; doi:10.1093/annonc/mdm083
[Abstract] [Full Text] [PDF] [Request Permissions]

hematologic malignancies:

NL Bartlett, D Niedzwiecki, JL Johnson, JW Friedberg, KB Johnson, K van Besien, AD Zelenetz, BD Cheson, and GP Canellos For the Cancer Leukemia Group B

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804
Annals of Oncology Advance Access published on April 10, 2007
Ann Oncol 18: 1071-1079; doi:10.1093/annonc/mdm090
[Abstract] [Full Text] [PDF] [Request Permissions]

FH van Tiel, MM Harbers, PHW Terporten, RTC van Boxtel, AG Kessels, GBWE Voss, and HC Schouten

Normal hospital and low-bacterial diet in patients with cytopenia after intensive chemotherapy for hematological malignancy: a study of safety
Annals of Oncology Advance Access published on March 16, 2007
Ann Oncol 18: 1080-1084; doi:10.1093/annonc/mdm082
[Abstract] [Full Text] [PDF] [Request Permissions]

M Björkholm, H Hagberg, H Holte, S Kvaloy, L Teerenhovi, H Anderson, E Cavallin-Ståhl, J Myhre, H Pertovaara, Å Öst, B Nilsson, and E Ösby

Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up
Annals of Oncology Advance Access published on March 15, 2007
Ann Oncol 18: 1085-1089; doi:10.1093/annonc/mdm073
[Abstract] [Full Text] [PDF] [Request Permissions]

Palliative care:

M Miyashita, M Sanjo, T Morita, K Hirai, and Y Uchitomi

Good death in cancer care: a nationwide quantitative study
Annals of Oncology Advance Access published on March 12, 2007
Ann Oncol 18: 1090-1097; doi:10.1093/annonc/mdm068
[Abstract] [Full Text] [PDF] [Request Permissions]

phase I and pharmacokinetics:

WP Steward, M Middleton, A Benghiat, PM Loadman, C Hayward, S Waller, S Ford, G Halbert, LH Patterson, and D Talbot

The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study
Annals of Oncology Advance Access published on April 17, 2007
Ann Oncol 18: 1098-1103; doi:10.1093/annonc/mdm120
[Abstract] [Full Text] [PDF] [Request Permissions]

epidemiology:

W Garavello, M Rossi, JK McLaughlin, C Bosetti, E Negri, P Lagiou, R Talamini, S Franceschi, M Parpinel, L Dal Maso, and C La Vecchia

Flavonoids and laryngeal cancer risk in Italy
Annals of Oncology Advance Access published on March 19, 2007
Ann Oncol 18: 1104-1109; doi:10.1093/annonc/mdm078
[Abstract] [Full Text] [PDF] [Request Permissions]

E de Vries, S Houterman, MLG Janssen-Heijnen, T Nijsten, SAM van de Schans, AMM Eggermont, and JWW Coebergh

Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands
Annals of Oncology Advance Access published on April 13, 2007
Ann Oncol 18: 1110-1116; doi:10.1093/annonc/mdm087
[Abstract] [Full Text] [PDF] [Request Permissions]

letters to the editor:

O Rixe, B Billemont, and H Izzedine

Hypertension as a predictive factor of Sunitinib activity
Ann Oncol 18: 1117; doi:10.1093/annonc/mdm184
[Extract] [Full Text] [PDF] [Request Permissions]

G Di Lorenzo and S De Placido

Re: Perabo FGE and Muller SC. New agents for treatment of advanced transitional cell carcinoma. Ann Oncol 2007; 18: 835–843.
Ann Oncol 18: 1118; doi:10.1093/annonc/mdm197
[Extract] [Full Text] [PDF] [Request Permissions]

G Ferretti and P Papaldo

Granulocyte colony-stimulating factor-associated complications and increase in leukocyte number
Ann Oncol 18: 1118-1119; doi:10.1093/annonc/mdm196
[Extract] [Full Text] [PDF] [Request Permissions]

S Deandrea, P Bertuccio, L Chatenoud, S Franceschi, D Serraino, and C La Vecchia

Reply to ‘Alcohol consumption and risk of Hodgkin's lymphoma and multiple myeloma: a multicentre case-control study’ by Gorini et al.
Ann Oncol 18: 1119-1121; doi:10.1093/annonc/mdm203
[Extract] [Full Text] [PDF] [Request Permissions]

LY Dirix, H Maes, and C Sweldens

Treatment of arterial hypertension (AHT) associated with angiogenesis inhibitors
Ann Oncol 18: 1121-1122; doi:10.1093/annonc/mdm205
[Extract] [Full Text] [PDF] [Request Permissions]

M Björkholm, M Hultcrantz, S Kristinsson, L Brandt, A Ekbom, and Å Derolf

Suicide in multiple myeloma and acute myeloid leukaemia
Ann Oncol 18: 1122-1123; doi:10.1093/annonc/mdm207
[Extract] [Full Text] [PDF] [Request Permissions]

T Armbrust, M Sobotta, and G Ramadori

Follow up of three cases after adjuvant treatment of high risk gastrointestinal stromal tumors with Imatinib
Ann Oncol 18: 1123-1125; doi:10.1093/annonc/mdm266
[Extract] [Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.